Leiden-based biotech company VitroScan secures 1.9M from National Growth Fund's Biotech Booster program - Silicon CanalsVitroScan secures €1.9M funding to enhance chemotherapy response prediction for ovarian cancer patients, preparing for clinical application.Biotech Booster aims to commercialize biotechnology research through funding, mentorship, and collaboration.